PUNE, India, January 2, 2018 /PRNewswire/ -- According to a new market research "Cancer/Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast,...
from PR Newswire: //www.prnewswire.co.uk/news-releases/cancertumor-profiling-market-worth-874-billion-usd-by-2022-667682223.html
No comments:
Post a Comment